Progression of clinical study on the selective cyclooxygenase-2 inhibitor
Ren Jin-min
Abstract
Ren Jin-min
Abstract
The selective cyclooxygenase-2 inhibitor has good anti-inflammatory and analgesic effect,and the adverse effects significantly diminish compared with non-selective NSAIDs.Therefore,it is widely used to treat the arthritic pain or other kinds of pain.In this paper, the clinical application and adverse drug reaction of such selective cyclooxygenase-2 inhibitors as meloxicam,nimesulide,celecoxib and parecoxib were evaluated respectively.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The selective cyclooxygenase-2 inhibitor has good anti-inflammatory and analgesic effect,and the adverse effects significantly diminish compared with non-selective NSAIDs.Therefore,it is widely used to treat the arthritic pain or other kinds of pain.In this paper, the clinical application and adverse drug reaction of such selective cyclooxygenase-2 inhibitors as meloxicam,nimesulide,celecoxib and parecoxib were evaluated respectively.
Key concepts: Meloxicam, Nimesulide, Medicine, Celecoxib, Cyclooxygenase, Parecoxib, Adverse effect, Analgesic